| 1 |
Ashworth TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death[J]. Aust Med J, 1869,14:146-149.
|
| 2 |
Paget S. The distribution of secondary growths in cancer of the breast[J].Lancet, 1889,1:571-573.
|
| 3 |
Pachmann K, Clement JH, Schneider CP, et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer[J]. Clin Chem Lab Med, 2005, 43:617-627.
|
| 4 |
Schindlbeck C, Andergassen U, Hofmann S, et al. Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients[J].J Cancer Res Clin Oncol, 2013,139:1055-1062.
|
| 5 |
Vogel I, Kalthoff H. Disseminated tumor cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas[J]. Virehows Arch, 2001,439:109-117.
|
| 6 |
Zieglschmid V, Hollmann C, Bocher O. Detection of disseminated tumor cells in peripheral blood[J].Crit Rev Clin Lab Sci, 2005,42:155-196.
|
| 7 |
Riethdorf S, Pantel K. Disseminated Tumor Cells in Bone Marrow and Circulating Tumor Cells in Blood of Breast Cancer Patients: Current State of Detection and Characterization[J]. Pathobiology, 2008, 75:140-148.
|
| 8 |
Fehm T, Müller V, Alix-Panabières C, et al. Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance[J]. Breast Cancer Res, 2008,10 Suppl 1: S1.
|
| 9 |
Jeffrey S, Ross MD, Elzbieta A, et al. Circulating and Disseminated Tumor Cells in the Management of Breast Cancer[J]. Am J Clin Pathol, 2009,132:237-245.
|
| 10 |
Mostert B, Sleijfer S, Foekens JA, et al. Circulating tumor cells (CTCs):Detection methods and their clinical relevance in breast cancer[J].Cancer Treat Rev, 2009,35:463-474.
|
| 11 |
Lin HK, Zheng S, Williams AJ, et a1. Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells, Marija Balic[J]. Clin Cancer Res, 2010,16:5011-5018.
|
| 12 |
Ntoulia M, Stathopoulou A, Ignatiadis M, et al. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR[J].Clin Biochem, 2006,39:879-887.
|
| 13 |
Mostert B, Kraan J, Bolt-de Vries J, et al. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146[J]. Breast Cancer Res Treat, 2011,127:33-41.
|
| 14 |
Budd GT, Cristofanilli M, Ellis MJ, et al. Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer[J].Clin Cancer Res, 2006,12:6403-6409.
|
| 15 |
Tanter M, Bercoff J, Athanasiou A, et al. Quantitative assessment of breast lesion viscoelasticity: initial clinical results using supersonic shear imaging[J]. Ultrasound Med Biol, 2008,34:1373-1386.
|
| 16 |
游姗姗, 朱庆莉, 张璟, 等. 超声光散射成像诊断乳腺病变[J].中国医学影像技术, 2008,24:1777-1780.
|
| 17 |
Quinn EM, Coveney AP, Redmond HP. Use of magnetic resonance imaging in detection of breast cancer recurrence: a systematic review[J].Ann Surg Oncol, 2012,19:3035-3041.
|
| 18 |
Hayes DF, Smerage J. Is there a role for circulating tumor cells in the management of breast cancer?[J] Clin Cancer Res, 2008,14:3646-3650.
|
| 19 |
Maestro LM, Sastre J, Rafael SB, et al. Circulating tumor cells in solid tumor in metastatic and localized stages[J]. Anticancer Res,2009,29:4839-4843.
|
| 20 |
Cristofanilli M, Budd GT, Ellis MJ, et a1. Circulating tumor cells,disease progression, and survival in metastatic breast cancer[J]. N Engl J Med, 2004,351:781-791.
|
| 21 |
de Albuquerque A, Kubisch I, Stölzel U, et al. Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients[J]. J Transl Med, 2012,10:222.
|
| 22 |
Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases[J]. Clin Cancer Res, 2004,10:6897-6904.
|
| 23 |
Mikhitarian K, Martin RH, Ruppel MB, et al. Detection of mammaglobin mRNA in peripheral blood is ass-ociated with high grade breast cancer: interim results of a prospective cohort study[J].BMC Cancer, 2008,8: 55.
|
| 24 |
Ignatiadis M, Xenidis N, Perraki M, et al. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer[J]. J Clin Oncol, 2007,25: 5194-5202.
|
| 25 |
Agrawal AK, Jeleń M, Rudnicki J, et al. Molecular markers (c-erbB-2,p53) in breast cancer[J]. Folia Histochem Cytobiol, 2008,46:449-455.
|
| 26 |
Fehm T, Müller V, Aktas B, et al. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective,multicenter trial[J]. Breast Cancer Res Treat, 2010,124:403-412.
|
| 27 |
Liu Z, Fusi A, Schmittel A, et al. Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine[J]. Cancer Biol Ther, 2010,10:860-864.
|
| 28 |
Nadal R, Fernandez A, Sanchez-Rovira P, et al. Biomarkers characterization of circulating tumour cells in breast cancer patients[J].Breast Cancer Res, 2012,14:R71.
|
| 29 |
Leong AS, Zhuang Z. The changing role of pathology in breast cancer diagnosis and treatment[J]. Pathobiology, 2011,78:99-114.
|